Danna Breen has succeeded Kendra Bence as head of obesity discovery at Pfizer after nearly 14 years with the company as a scientist and research fellow.
July 10, 2026 07:00 AM EDT
Peer Review
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
Alex Hoffman
Copy Chief and News Editor
Pfizer made one thing clear this week: It's officially back in the obesity race.
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could…
Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on…
Verdiva Bio names ex-Metsera CMO Steve Marso as its new medical chief ahead of interim EVOLVE-2 data on its oral GLP-1 pill…
It’s a sign of the times that this year’s American Diabetes Association (ADA) Scientific Sessions meeting in New Orleans featured…
